Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-11

Clinical Trial Update: Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety and immunogenicity of a Venezuelan equine encephalomyelitis vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venezuelan equine encephalomyelitis vaccine (VEE vaccine)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Venezuelan Equine Encephalomyelitis Virus Disease | Phase 2 | Status: UNKNOWN